title: Nuclear recruitment of A1p145 subunit of replication factor C in the early G1 phase of the cell cycle in Faza 567 hepatoma cell line and hepatocyte primary cultures.
abstract: Using a combination of immunoprecipitation and Western blotting with Faza 567 hepatoma cell extracts revealed that the large subunit of replication factor C (A1p145; mRFC140) was in a complex with proliferating cell nuclear antigen (PCNA). Western blotting showed that A1p145 was more abundant in nuclear extracts from butyrate-treated hepatoma cells which blocks the cells in the G1 phase of the cell cycle than from routinely cultured cells. Indirect immunoperoxidase analysis of G1 blocked Faza hepatoma cells localized A1p145 protein predominantly in the nucleoli. When hepatoma cells were stimulated to progress toward the S phase, A1p145 protein was then observed in both the cytoplasm and the nucleoplasm of these cells. Studies with early cultured normal hepatocytes which are progressing from G0 towards G1, also showed a nucleolus distribution for A1p145. This is the first demonstration in mammalian cells that the large subunit of replication factor C is associated with PCNA in the nucleus and that its distribution within cells changes during the cell cycle.
authors.affiliation: Unité de Recherches Hépatologiques U 49 de l'INSERM, CHRU Pontchaillou, Rennes, France.
authors.forename: F
authors.initials: F
authors.lastname: Levavasseur
authors.forename: P D
authors.initials: PD
authors.lastname: Burbelo
authors.forename: S
authors.initials: S
authors.lastname: Cariou
authors.forename: J
authors.initials: J
authors.lastname: Liétard
authors.forename: Y
authors.initials: Y
authors.lastname: Yamada
authors.forename: B
authors.initials: B
authors.lastname: Clément
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D002467:Cell Nucleus / Q000378:metabolism*; D003593:Cytoplasm / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*; D016193:G1 Phase / Q000187:drug effects; D018398:Homeodomain Proteins; D007124:Immunoenzyme Techniques; D007163:Immunosorbent Techniques; D008099:Liver / Q000378:metabolism* / Q000648:ultrastructure; D008114:Liver Neoplasms, Experimental / Q000378:metabolism* / Q000648:ultrastructure; D046911:Macromolecular Substances; D008297:Male; D015778:Minor Histocompatibility Antigens; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2; D051381:Rats; D017207:Rats, Sprague-Dawley; D051818:Replication Protein C; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D014407:Tumor Cells, Cultured
chemical_list: C096816:BCL2-related protein A1; D002087:Butyrates; D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; C096063:MATA1 protein, S cerevisiae; D046911:Macromolecular Substances; D015778:Minor Histocompatibility Antigens; D018809:Proliferating Cell Nuclear Antigen; D019253:Proto-Oncogene Proteins c-bcl-2; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D020148:Butyric Acid; D051818:Replication Protein C